Business Wire

MAVENIR

4.4.2022 09:02:11 CEST | Business Wire | Press release

Share
Vodafone Portugal Awards Mavenir Cloud-Native Converged Packet Core

Vodafone Portugal, a leading telecom provider in Portugal, and Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced that Vodafone Portugal will be using the MAVcore solution for its fully containerised Converged Packet Core network after the selection of Mavenir as strategic 5G Converged Core supplier.

The MAVcore family includes Mavenir’s leading-edge Converged Packet Core and Policy Control solution delivering a next-generation modernised data network. The MAVcore solution will allow the transformation to a containerised and automated cloud-native network – providing the flexibility for future mobile network evolution, including the launch of disruptive and innovative 5G Stand Alone applications for Vodafone customers in Portugal.

The 5G Converged Packet Core solution is designed with cloud-native containerised techniques providing a fully scalable and virtualised network architecture. The solution uses software running on commercial off-the-shelf (COTS) hardware that provides cost-effectiveness, flexibility, and agility. Mavenir Converged Packet Core with multi-access support (2G, 3G, 4G, 5G) allows Communication Service Providers (CSPs) like Vodafone to plan for future growth and a greater focus on security and reliability. It simplifies network transformation and enables operational efficiencies with complete automation.

Paulino Correa, Network Director, Vodafone Portugal, said; “The industry defines several steps for 5G – the first one was launched back in November – but it is the second step, the 5G Stand Alone Core, that brings the more powerful technology revolution in terms of use cases. For our strategic 5G Stand Alone Core supplier, we wanted a vendor who would have innovation at its heart and equally provide us with a technically leading converged Packet Core solution. We have been working on 5G SA with Mavenir in our lab for over 1 year and are now ready to deliver a cloud-native Packet Core platform that will transform our network and prepare it for powerful applications and differentiating use cases, as the 5G solution evolves.”

Stefano Cantarelli, Chief Marketing Officer, Mavenir, said; “Mavenir has been working with Vodafone Group across various projects and we are delighted to now be part of their next-generation Converged Packet Core network under the Spring 3 Cosmos programme – we look forward to transforming Vodafone Portugal’s existing network into a dynamic, agile, fully automated for simplified operation and cloud-native based platform.”

About Mavenir:

Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry's only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. www.mavenir.com

About Vodafone Portugal:

Vodafone Portugal is part of the Vodafone Group which is a leading technology communications company. Vodafone is the largest mobile and fixed network operator in Europe and a leading global IoT connectivity provider. Vodafone Group operates mobile and fixed networks in 21 countries and partner with mobile networks in 48 more. Vodafone Portugal currently serves 3.6 million homes and businesses with its next generation network and has over 4.6 million mobile customers.
https://www.vodafone.pt/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye